FC

Foresite Capital Management IV, LLC

13F
Foresite Capital Management IV, LLC
Last update 2025-05-15 5 Stocks (1 new)
Value $111.00 Mil Turnover 25 %
Countries:
Top Holdings: PHVS(62.35%)MAZE(20.93%)LYEL(7.75%)KURA(6.61%)RLAY(2.36%)
Summary Stock Picks Current Portfolio
Foresite Capital Management IV... Top Holdings of 2025-03-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
PHVS 		Pharvaris NV
4,410,581
69,246.1
+0.29%
62.350
+0.18%
8.090
+8.61%
-12.47%
914.4
Biotechnology
MAZE 		Maze Therapeutics Inc
2,111,919
23,252.2
New Holding
20.930
+20.93%
4.820
+10.23%
0%
566.3
Biotechnology
LYEL 		Lyell Immunopharma Inc
800,400
8,612.3
+92.29%
7.750
+3.72%
5.420
-12.17%
-0.31%
189.0
Biotechnology
KURA 		Kura Oncology Inc
1,111,882
7,338.4
-35.61%
6.610
-4.93%
1.280
-12.60%
-22.73%
582.6
Biotechnology
RLAY 		Relay Therapeutics Inc
1,000,000
2,620.0
0%
2.360
0%
0.580
-3.45%
-18.45%
576.1
Biotechnology

Foresite Capital Management IV, LLC's Historical Top Holdings Breakdowns

Foresite Capital Management IV, LLC's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
MAZE 		Maze Therapeutics Inc2025-03-31New Buy
+20.93%
●
10.57 ($12.04) 15.95
$12.93
7.39%
New holding
2,111,919
2,111,919
KURA 		Kura Oncology Inc2025-03-31Reduce
-4.93%
●
6.6 ($7.79) 9.05
$6.73
-13.61%
Reduce -35.61%
1,111,882
-615,000
LYEL 		Lyell Immunopharma Inc2025-03-31Add
+3.72%
●
9.67 ($12.25) 14.86
$12.76
4.16%
Add 92.29%
800,400
7,682,999
PHVS 		Pharvaris NV2025-03-31Add
+0.18%
●
14.9 ($16.87) 19.54
$16.78
-0.53%
Add 0.29%
4,410,581
12,700
SNDX 		Syndax Pharmaceuticals Inc2024-12-31Sold Out
-11.01%
●
12.52 ($17.07) 21.81
$11.45
-32.92%
Sold Out
0
-875,000
KURA 		Kura Oncology Inc2024-12-31Reduce
-1.57%
●
8.51 ($14.31) 18.58
$6.73
-52.97%
Reduce -6.65%
1,726,882
-123,065
RLAY 		Relay Therapeutics Inc2024-09-30New Buy
+4.63%
●
6.24 ($7.47) 9.51
$3.36
-55.02%
New holding
1,000,000
1,000,000
PHVS 		Pharvaris NV2024-09-30Add
+1.26%
●
15.73 ($18.27) 21.4
$16.78
-8.16%
Add 2.42%
4,397,881
104,027
KNTE Unlock Delisted Kinnate Biopharma Inc2024-06-30Sold Out
-13.00%
●
2.65 ($2.65) 2.66
$2.65
0%
Sold Out
0
-9,671,643
PHVS 		Pharvaris NV2024-06-30Add
+3.22%
●
15.67 ($20.35) 24.59
$16.78
-17.54%
Add 6.31%
4,293,854
255,012

Foresite Capital Management IV, LLC Total Holding History ($B)

To

Foresite Capital Management IV, LLC's Asset Allocation

To

Foresite Capital Management IV, LLC Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Foresite Capital Management IV, LLC's Hypothetical Growth since 2025-03-31

Foresite Capital Management IV, LLC's Yearly Returns

Year Portfolio % % Excess Gain %

Foresite Capital Management IV, LLC's Holdings Heat Map

Size field:

Foresite Capital Management IV, LLC's Holdings Bubble Chart

Foresite Capital Management IV, LLC News

  • 1

Discussions on Foresite Capital Management IV, LLC

No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.